We are live on ! Find out more
AFC

Ares Financial Consulting Portfolio holdings

AUM $139M
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$12.1M
Cap. Flow
+$897K
Cap. Flow %
0.64%
Top 10 Hldgs %
40.89%
Holding
1,171
New
105
Increased
235
Reduced
84
Closed
39

Top Buys

Rank Stock Value
1
LTPZ icon
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
+$567K
2
DFIC icon
Dimensional International Core Equity 2 ETF
DFIC
+$430K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$357K
4
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$305K
5
FRDM icon
Freedom 100 Emerging Markets ETF
FRDM
+$261K

Top Sells

Rank Stock Value
1
DFAU icon
Dimensional US Core Equity Market ETF
DFAU
+$443K
2
USFR icon
WisdomTree Floating Rate Treasury Fund
USFR
+$430K
3
AVUS icon
Avantis US Equity ETF
AVUS
+$357K
4
VTIP icon
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
+$328K
5
DFAI
Dimensional International Core Equity Market ETF
DFAI
+$276K

Sector Composition

Rank Sector Weight
1 Technology 11.35%
2 Communication Services 4.91%
3 Industrials 4.54%
4 Financials 3.59%
5 Consumer Discretionary 3.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIRJ
1076
Montana Technologies Corp
AIRJ
$431M
$587 ﹤0.01%
106
– –
PKX icon
1077
POSCO
PKX
$16.6B
$565 ﹤0.01%
11
– –
WHD icon
1078
Cactus
WHD
$5.28B
$564 ﹤0.01%
11
– –
MHH icon
1079
Mastech Digital
MHH
$94.4M
$557 ﹤0.01%
72
– –
HTFL
1080
Heartflow Inc
HTFL
$2.34B
$557 ﹤0.01%
+19
New +$571
OLN icon
1081
Olin
OLN
$2.13B
$555 ﹤0.01%
28
– –
RYTM icon
1082
Rhythm Pharmaceuticals
RYTM
$7.62B
$555 ﹤0.01%
+5
New +$452
INSM icon
1083
Insmed
INSM
$21.5B
$533 ﹤0.01%
+5
New +$605
LBRDA icon
1084
Liberty Broadband Class A
LBRDA
$5.17B
$532 ﹤0.01%
16
– –
NOG icon
1085
Northern Oil and Gas
NOG
$2.22B
$526 ﹤0.01%
29
– –
ZTO icon
1086
ZTO Express
ZTO
$18B
$515 ﹤0.01%
23
– –
TFX icon
1087
Teleflex
TFX
$6.06B
$507 ﹤0.01%
+4
New +$512
NUVL
1088
DELISTED
Nuvalent
NUVL
$494 ﹤0.01%
+4
New +$430
REFI
1089
Chicago Atlantic Real Estate Finance
REFI
$252M
$472 ﹤0.01%
44
– –
ARDX icon
1090
Ardelyx
ARDX
$1.24B
$459 ﹤0.01%
+90
New +$549
CRNX icon
1091
Crinetics Pharmaceuticals
CRNX
$8.91B
$449 ﹤0.01%
12
– –
JBIO
1092
Jade Biosciences
JBIO
$1.32B
$444 ﹤0.01%
+20
New +$417
INVH icon
1093
Invitation Homes
INVH
$18.1B
$423 ﹤0.01%
14
– –
LI icon
1094
Li Auto
LI
$12.6B
$411 ﹤0.01%
35
– –
IWB icon
1095
iShares Russell 1000 ETF
IWB
$49.8B
$410 ﹤0.01%
1
– –
SUI icon
1096
Sun Communities
SUI
$14.7B
$402 ﹤0.01%
3
– –
RC
1097
Ready Capital
RC
$287M
$394 ﹤0.01%
225
– –
JANX icon
1098
Janux Therapeutics
JANX
$976M
$384 ﹤0.01%
+25
New +$362
DFTX
1099
Definium Therapeutics
DFTX
$5.62B
$376 ﹤0.01%
+8
New +$198
BHC icon
1100
Bausch Health
BHC
$2.35B
$345 ﹤0.01%
70
– –
42 43
44
45 46

Similar funds

LIP
Landmark Investment Partners West Palm Beach, Florida $139M AUM 16.97% 1-Year Est. Return
KLCM
KG&L Capital Management Saint Francisville, Louisiana $139M AUM 26.97% 1-Year Est. Return
BCCM
Black Cypress Capital Management Ponte Vedra Beach, Florida $139M AUM 16.22% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $139M AUM
BCA
Buckley Capital Advisors Miami Beach, Florida $139M AUM
SFC
Summit Financial Consulting Sterling Heights, Michigan $140M AUM 9.47% 1-Year Est. Return
CFWMA
Center for Wealth Management Advisory Milford, Ohio $139M AUM
ACP
Argyle Capital Partners Los Angeles, California $139M AUM 17.29% 1-Year Est. Return

Ares Financial Consulting's Q2 2026 Portfolio in Review

As of Q2 2026, Ares Financial Consulting held 1,171 positions worth $139M, up 9.5% from $127M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Ares Financial Consulting's Q2 2026 filing shows 105 new, 235 increased, 84 reduced and 39 closed positions. Its largest new stake was AstraZeneca: 486 shares worth $92.2K. The largest sale was Dimensional US Core Equity Market ETF, an estimated $443K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Communication Services and Industrials.

  • Ares Financial Consulting's largest Q2 2026 buy was AstraZeneca: 486 shares worth $92.2K.
  • Ares Financial Consulting added most to PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q2 2026, an estimated $567K increase.
  • Ares Financial Consulting's biggest Q2 2026 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $443K.
  • Ares Financial Consulting fully exited Vanguard FTSE All-World ex-US ETF in Q2 2026, selling an estimated $203K.
  • Ares Financial Consulting's ten largest holdings make up 41% of its $139M portfolio in Q2 2026.
  • Ares Financial Consulting opened 105 new positions and closed 39 in Q2 2026.
  • Ares Financial Consulting's portfolio value rose 9.5% quarter-over-quarter to $139M.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.